← Leaderboards
Jong-Min Lee
Massachusetts General Hospital
$5,033,680
Attributed
$5,033,680
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $989.6K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,033,680 · 2
By mechanism
R01$5,033,680 · 2
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Ihn Sik Seong$4,586,328
- Marcy Macdonald$9,010,586
- Jeffrey D Rothstein$32,739,978
- Herminia D Rosas$18,624,312
- Beth Ann Stevens$21,074,664
Others in their field
Other Emerging Leaders on “Mutation”
- Leonard Freedman · Leidos Biomedical Research, Inc.$85,874,322
- John Damon Chodera · Sloan-Kettering Inst Can Research$48,421,310
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$38,744,543
- Lynn Briscoe · Leidos Biomedical Research, Inc.$38,032,945
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- James Dale Berry · Brigham And Women'S Hospital$19,118,191
Research focus
MutationMolecular PhenotypeInduced Pluripotent Stem CellHuntington DiseaseKnock-In MouseMolecularClustered Regularly Interspaced Short Palindromic RepeatsEffective TherapyGenesGeneticInnovationInvestigationAnimal ModelLocationAffectBiological ModelsBrainCag RepeatFutureCell ModelCellsGene TargetingAllelesNeuronal Differentiation
Grant awards (10)
Therapeutic Potential of Base Editing Strategies to Convert CAG to CAA in Huntington's Disease$563,700
R01 · FY2025 · NS · contact PI
Therapeutic Potential of Base Editing Strategies to Convert CAG to CAA in Huntington's Disease$484,263
R01 · FY2024 · NS · contact PI
Therapeutic Potential of Base Editing Strategies to Convert CAG to CAA in Huntington's Disease$503,051
R01 · FY2023 · NS · contact PI
Therapeutic potential of base editing strategies to convert CAG to CAA in Huntington's Disease$558,639
R01 · FY2022 · NS · contact PI
Genetic foundation for complete mutant allele-specific CRISPR in neurodegenerative diseases$430,979
R01 · FY2022 · NS · contact PI
Therapeutic potential of base editing strategies to convert CAG to CAA in Huntington's Disease$520,676
R01 · FY2021 · NS · contact PI
Genetic foundation for complete mutant allele-specific CRISPR in neurodegenerative diseases$456,205
R01 · FY2021 · NS · contact PI
Genetic foundation for complete mutant allele-specific CRISPR in neurodegenerative diseases$495,210
R01 · FY2020 · NS · contact PI
Genetic foundation for complete mutant allele-specific CRISPR in neurodegenerative diseases$495,210
R01 · FY2019 · NS · contact PI
Genetic foundation for complete mutant allele-specific CRISPR in neurodegenerative diseases$525,747
R01 · FY2018 · NS · contact PI